Aldeyra Therapeutics, Inc. (ALDX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Aldeyra Therapeutics, Inc. (ALDX)
Go deeper and ask any question about ALDX
Company Performance
Current Price
as of Sep 13, 2024$6.03
P/E Ratio
N/A
Market Cap
$358.31M
Description
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Metrics
Overview
- HQLexington, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerALDX
- Price$6.03-2.58%
Trading Information
- Market Cap$358.31M
- Float96.59%
- Average Daily Volume (1m)440,143
- Average Daily Volume (3m)504,510
- EPS-$0.64
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$16.85M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$17.95M
- EV$131.97M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account